VR Adviser »

Alto Neuroscience shares owned by VR Adviser

Quarter-by-quarter ownership of Alto Neuroscience (ANRO) shares owned by VR Adviser from 13F filings

Historical chart of VR Adviser investment in Alto Neuroscience

Tip: Access up to 7 years of quarterly data

All positions including Alto Neuroscience held by VR Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alto Neuroscience by VR Adviser

Quarter filed Position value Share count Share price at filing
2026-03-31 $11M 500k 22.48

More positions owned by VR Adviser

Apogee Therapeutics (APGE)
Erasca (ERAS)
Oruka Therapeutics (ORKA)
Spyre Therapeutics Com New (SYRE)
Kalvista Pharmaceuticals (KALV)
Dianthus Therapeutics (DNTH)
Damora Therapeutics Com New (DMRA)
Ocular Therapeutix (OCUL)
Cogent Biosciences (COGT)
Miragen Therapeutics (VRDN)
Savara (SVRA)
Enliven Therapeutics (ELVN)
Oric Pharmaceuticals (ORIC)
Vor Biopharma Com New (VOR)
Maze Therapeatics (MAZE)

View all positions for VR Adviser

Top funds holding Alto Neuroscience

Falcon Edge Capital
Commodore Capital
Vestal Point Capital
Perceptive Advisors
Vanguard Group
Vanguard Capital Management
Franklin Resources
Vivo Capital
Armistice Capital
Millennium Management
72 Investment Holdings
BlackRock
Ikarian Capital
Point72 Asset Management
VR Adviser

View all funds holding Alto Neuroscience